Perioperative Treatment Strategies for Advanced Melanoma and Non-Melanoma Skin Cancers
Document Type
Journal Article
Publication Date
10-6-2025
Journal
Journal of the American Academy of Dermatology
DOI
10.1016/j.jaad.2025.09.098
Keywords
cutaneous oncology; dermatologic surgery; immunotherapy; neoadjuvant; perioperative
Abstract
Perioperative therapies, including neoadjuvant and neoadjuvant plus adjuvant, are developing and promising approaches to improve management of cutaneous malignancies. This review summarizes key studies of perioperative therapies to guide clinical practice in treatment of melanoma, cutaneous squamous cell carcinoma, basal cell carcinoma, and Merkel cell carcinoma. The clinical trials and real-world studies reviewed routinely demonstrated that perioperative strategies, especially with immune checkpoint inhibitors, yielded high pathological response rates, improved survival, reduced treatment side effects, and decreased surgical morbidity. Moreover, perioperative therapies could enable treatment step down and even avoidance of surgery altogether.
APA Citation
Sun, Kennedy H.; Thakker, Sach; Greenzaid, Jonathan; Belzberg, Micah; Miller, David M.; and Patel, Vishal A., "Perioperative Treatment Strategies for Advanced Melanoma and Non-Melanoma Skin Cancers" (2025). GW Authored Works. Paper 8307.
https://hsrc.himmelfarb.gwu.edu/gwhpubs/8307
Department
Dermatology